2SE-29486-77986
3 vaccinations
1 coded response
16 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 441 / OH
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Dose 1 — Pfizer-BioNTech
-
2021-03-27
Registered in v-safe
-
2021-03-27
Dose 2 — Pfizer-BioNTech
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-28
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-03-29
- 2021-03-30
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-12
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-10
- 2021-06-26
- 2021-09-25
-
2021-11-05
Dose 3 — Pfizer-BioNTech
-
2022-03-27
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: GoodFree text: Both my baby and I had COVID in January 2022MedDRA releases: 2024-11 · check-in free text available
- 2022-11-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Pfizer-BioNTech | |
| 2 | 2021-03-27 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-28 | priority 2/3 |
Free text
Release 11 — 12 months, dose 2
Symptoms: Both my baby and I had COVID in January 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release